Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Foundation Fighting Blindness and the Gund Vision Fund Receive Second $1 Million Gift from A Race Against Blindness to Advance Gene-Agnostic Therapeutic Approaches


      News provided by

      Foundation Fighting Blindness

      Nov 17, 2026, 10:00 ET

      Share this article

      Share this article


      The commitment directs $700,000 to the Gund Vision Fund, to be matched by the Gordon and Llura Gund Foundation as part of the Fund's ongoing fundraising campaign, and $300,000 to a Foundation Fighting Blindness research award advancing a regenerative, gene-agnostic therapy

      COLUMBIA, Md. and RALEIGH, N.C., Nov. 17, 2026 /PRNewswire/ -- The Foundation Fighting Blindness and its venture philanthropy arm, the Gund Vision Fund, today announced a second $1 million commitment from A Race Against Blindness, building on the partnership the organizations launched earlier this year, to advance gene-agnostic therapeutic approaches for inherited retinal diseases. The commitment directs $700,000 to the Gund Vision Fund and $300,000 to a Foundation Fighting Blindness research award. The Gordon and Llura Gund Foundation Challenge, a donor match that doubles new and increased gifts to the Fund, will match the $700,000 dollar for dollar, bringing the total impact to the Fund to $1.4 million.

      Continue Reading
      Foundation Fighting Blindness and the Gund Vision Fund
      Foundation Fighting Blindness and the Gund Vision Fund

      The new commitment amplifies A Race Against Blindness's initial $1 million gift earlier this year and reflects the continued generosity of the organization's community of supporters. Founded in 2023 by Dr. Stephen Johnston and Kristina Johnston after their son was diagnosed with retinitis pigmentosa (RP) caused by Bardet-Biedl syndrome (BBS), the family-run nonprofit has directed millions of dollars toward research for RP and BBS, with a focus on pediatric inherited retinal diseases and on moving promising therapies from concept to clinic with urgency.

      Advancing Gene-Agnostic Approaches Across the Gund Vision Fund Portfolio
      The $700,000 directed to the Gund Vision Fund will support gene-agnostic therapeutic approaches across the Fund's portfolio, designed to benefit patients regardless of the underlying genetic cause of their disease. The Fund balances investments in gene-specific and gene-agnostic strategies, with portfolio companies pursuing neuroprotection to slow degeneration across all forms of RP, optogenetics-inspired approaches to restore light sensitivity, and cell therapies designed to restore function in surviving photoreceptors.

      "This commitment from A Race Against Blindness, again matched through the Gordon and Llura Gund Foundation Challenge, allows us to grow and diversify a portfolio of gene-agnostic approaches that may benefit the greater RP community," said Rusty Kelley, PhD, managing director of the Gund Vision Fund. "When partners reinvest, they help ensure that promising science continues moving closer to meaningful outcomes for patients."

      Funding Regenerative, Gene-Agnostic Research at the Foundation Fighting Blindness
      The remaining $300,000 commitment will advance gene-agnostic research through the Foundation Fighting Blindness preclinical science programs, and in particular the groundbreaking work of Dr. Jin Woo Kim at the Korea Advanced Institute of Science and Technology (KAIST). His research exemplifies the innovative approaches that have inspired A Race Against Blindness to expand its support for therapies with the potential to benefit patients across multiple forms of retinal disease.

      Dr. Kim's approach uses an antibody to inhibit the activity of PROX1, a protein that normally keeps Müller glia, the retina's support cells, from regenerating. By inhibiting PROX1, the therapy enables Müller glia to reprogram into retinal progenitor–like cells, which are immature cells that can develop into new light-sensing photoreceptors. The goal is to induce regenerative capacity in the mammalian eye, which does not naturally repair itself after retinal damage. In animal models of RP, this approach has restored visual function. Because it works by promoting retinal repair through Müller glia reprogramming, it has the potential to help patients with many forms of RP regardless of the underlying mutation. The award will refine the antibody and its delivery and advance the most durable candidates toward large-animal studies and, ultimately, first-in-human trials, with potential application to other retinal degenerative diseases.

      "Dr. Kim's research represents the kind of innovative science that makes this an especially exciting time for the retinal disease community," said Amy Laster, PhD, chief scientific officer of the Foundation Fighting Blindness. "We are grateful that A Race Against Blindness shares our enthusiasm and commitment to advancing a portfolio of promising approaches that could transform treatment for patients and families."

      "The continued innovative science at the Foundation and the Gund Vision Fund keeps us excited about what is possible in our partnership," said Dr. Stephen Johnston, co-founder of A Race Against Blindness. "Dr. Kim's regenerative research through the Foundation especially stood out to us, and we are glad our gift to the Fund also supports gene-agnostic approaches across its portfolio. These are the kinds of approaches that can help families like ours and so many others, whatever rare disease they are facing. We are all in this fight together, and we want to keep making an impact for as long as we can."

      As the world's leading private funder of retinal degenerative disease research, the Foundation Fighting Blindness has played a key role in driving the development of more than 60 retinal disease drug candidates now in clinical trials, a track record that made it a natural partner for A Race Against Blindness.

      About A Race Against Blindness
      A Race Against Blindness is a family-run nonprofit co-founded in 2023 by Dr. Stephen Johnston and Kristina Johnston after their son was diagnosed with retinitis pigmentosa caused by Bardet-Biedl syndrome. Through innovative fundraising and a focus on pediatric inherited retinal diseases, the organization has directed more than $7 million toward research for retinitis pigmentosa and Bardet-Biedl syndrome, working to move promising therapies from concept to clinic with urgency. For more information, visit ARaceAgainstBlindness.org.

      About the Foundation Fighting Blindness
      Established in 1971, the Foundation Fighting Blindness is the world's leading private funding source for retinal degenerative disease research. The Foundation has raised nearly $1 billion toward its mission of accelerating research for preventing, treating, and curing blindness caused by the entire spectrum of retinal degenerative diseases, including retinitis pigmentosa, age-related macular degeneration, Usher syndrome, and Stargardt disease. Visit FightingBlindness.org for more information.

      About the Gund Vision Fund
      The Gund Vision Fund is the venture philanthropy arm of the Foundation Fighting Blindness and a 501(c)(3) not-for-profit subsidiary. Launched in 2018 as the first and only fund solely dedicated to advancing therapeutics for inherited retinal diseases and dry age-related macular degeneration, the Fund bridges the critical funding gap between discovery-stage research and drug development. For more information, visit GundVisionFund.org.

      Media Contact:
      Chris Adams
      Foundation Fighting Blindness
      410-423-0585
      [email protected]

      SOURCE Foundation Fighting Blindness

      Modal title

      Also from this source

      Foundation Fighting Blindness and Eye & Ear Foundation of Pittsburgh Partner to Add FAM161A Cohort to Uni-Rare Natural History Study

      Foundation Fighting Blindness and Eye & Ear Foundation of Pittsburgh Partner to Add FAM161A Cohort to Uni-Rare Natural History Study

      The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, today announced a new...

      Foundation Fighting Blindness Launches First-Ever National VisionWalk Day

      Foundation Fighting Blindness Launches First-Ever National VisionWalk Day

      The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      Health Care & Hospitals

      Health Care & Hospitals

      Not For Profit

      Not For Profit

      Clinical Trials & Medical Discoveries

      Clinical Trials & Medical Discoveries

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.